High dose toremifene as a cisplatin modulator: Targeted plasma levels are achievable clinically

被引：0
|
作者：
Gandara, DR
Lara, P
Cadman, T
Lau, D
Uhrich, M
Turrell, C
Morgan, R
Dimery, I
Edelman, M
Perez, EA
Synold, T
Doroshow, J
Muggia, F
DeGregorio, M
机构：
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[2] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[3] Univ So Calif, Los Angeles, CA 90089 USA
[4] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1998年 / 46卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：148A / 148A
页数：1
相关论文
共 50 条
  • [21] Dosing strategies of high dose phytochemicals in the clinical setting: plasma levels of high dose resveratrol after 84 days of administration as a case study
    Johnson, Jeremy J.
    ANTI-CANCER DRUGS, 2015, 26 : E11 - E11
  • [22] Considerable plasma levels of a cytotoxic etoposide metabolite in patients undergoing high-dose chemotherapy
    Stremetzne, S
    Jaehde, U
    Kasper, R
    Beyer, J
    Siegert, W
    Schunack, W
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (06) : 978 - 979
  • [23] HIGH-DOSE METHYLPREDNISOLONE INCREASES PLASMA CYCLOSPORIN LEVELS IN RENAL-TRANSPLANT RECIPIENTS
    KLINTMALM, G
    SAWE, J
    LANCET, 1984, 1 (8379): : 731 - 731
  • [24] High venlafaxine plasma levels in psychiatric in-patients: Reason for dose adjustments or treatment discontinuation?
    Stephan, P. L.
    Ramseler, F.
    Etzensberger, M.
    Sirot, E. Jaquenoud
    DRUG SAFETY, 2006, 29 (10) : 955 - 955
  • [25] PLASMA PROGESTERONE LEVELS AFTER USING HIGH-DOSE SUPPOSITORIES - A PRELIMINARY-REPORT
    VANDERMEER, YG
    VANLOENEN, AC
    LOENDERSLOOT, EW
    JASZMANN, LJB
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1982, 4 (05) : 135 - 136
  • [26] PLASMA-LEVELS OF 7-HYDROXYMETHOTREXATE AFTER HIGH-DOSE METHOTREXATE TREATMENT
    MILANO, G
    THYSS, A
    RENEE, N
    SCHNEIDER, M
    NAMER, M
    BOUBLIL, JL
    LALANNE, CM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (01) : 29 - 32
  • [27] A SINGLE-DOSE-FINDING STUDY OF THE ANTIEMETIC EFFECT AND ASSOCIATED PLASMA-LEVELS OF MDL-72222 IN PATIENTS RECEIVING CISPLATIN
    LOGUE, J
    WILKINSON, P
    HAEGELE, KD
    ORWIN, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 27 (06) : 472 - 476
  • [28] Clinically Relevant Dose of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα), Lowers Serum Triglyceride Levels by Targeting Hepatic PPARα in Mice
    Zhang, Zhe
    Diao, Pan
    Zhang, Xuguang
    Nakajima, Takero
    Kimura, Takefumi
    Tanaka, Naoki
    BIOMEDICINES, 2022, 10 (07)
  • [29] A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients
    Vermeiden, Marlijn
    Mulder, Paul G.
    van den Broek, Walter W.
    Bruijn, Jan A.
    Birkenhager, Tom K.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (10) : 1337 - 1342
  • [30] Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
    Jiang, XC
    Bruce, C
    Mar, J
    Lin, M
    Ji, Y
    Francone, OL
    Tall, AR
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06): : 907 - 914
12345